ORIGINAL RESEARCH
Published on 26 Dec 2024
Efficacy and safety of anlotinib as maintenance treatment in extensive-stage small cell lung cancer: A single-armed single center retrospective study
doi 10.3389/fonc.2024.1462581
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Abnormal Angiogenesis in Tumors and the Improvement of Antiangiogenic Drugs
Abnormal Angiogenesis in Tumors and the Improvement of Antiangiogenic Drugs
758
Total downloads
3,472
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 03 Dec 2024
The role of N6-methyladenosine modification in tumor angiogenesis
doi 10.3389/fonc.2024.1467850
- 259 views
CASE REPORT
Published on 18 Nov 2024
Bevacizumab for the treatment of metastatic colorectal cancer complicated by abdominal aortic aneurysm and mural thrombus: a case report
doi 10.3389/fonc.2024.1416349
- 472 views
REVIEW
Published on 26 Aug 2024
Targeted anti-angiogenesis therapy for advanced osteosarcoma
doi 10.3389/fonc.2024.1413213
- 808 views
ORIGINAL RESEARCH
Published on 14 May 2024
Efficacy and safety of anlotinib in patients with desmoid fibromatosis: a retrospective analysis
doi 10.3389/fonc.2024.1399574
- 842 views
- 1 citation
Published in
Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Frontiers in Pharmacology
Cancer Molecular Targets and TherapeuticsOffline
- 4.4 impact factor
- 7.8 citescore
Impact
- 3,472Topic views
- 2,153Article views
- 758Article downloads